SOM Biotech

📍 Barcelona, Spain🗓 Founded 2009👥 15 employees💰 Last funded Jun 2017
SOM Biotech is a biopharmaceutical company focused on the accelerated discovery and development of therapies for orphan indications through a proprietary artificial intelligence-based drug discovery technology and developing strategic partnerships with major research centers and pharmaceutical companies. SOM AI PRO Technology is a proprietary AI-based validated drug discovery technology of SOM Biotech. After defining drug candidates through the technology, we successfully finished the Clinical Phase 2a of two drugs with very positive results. This will contribute to treating two relevant neurodegenerative diseases more effectively, meeting high safety and tolerance standards. One of our programs, for TTR Amyloidosis, after obtaining positive phase 2a results was out-licensed to NY based company. We have 3 programs in the preclinical stage, and 20 more programs in the early-stage pipeline, all obtained through the technology. We aim at developing value-creating collaborations with strategic partners, to leverage on the large intrinsic potential of SOMAI-PRO to discover new treatments to tackle some of the most acute diseases to accelerate the drug discovery process. Follow us on: https://twitter.com/SOMBIOTECH For collaborations: zimina@sombiotech.com
3
Total investors
0
Early stage
0
Mid stage
3
Late stage
2009
Founded
Investor geography1 country
Switzerland
2
Frequently asked questions
Who invested in SOM Biotech?
SOM Biotech has 3 investors on record on gritt.io and 3 late-stage investors.
When did SOM Biotech last raise funding?
The most recent investment in SOM Biotech recorded on gritt.io was in June 2017.
When was SOM Biotech founded?
SOM Biotech was founded in 2009.
What industry is SOM Biotech in?
SOM Biotech operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is SOM Biotech based?
SOM Biotech is headquartered in Barcelona, Spain.